You are here : Home > News Archive > CARBOGEN AMCIS AG Featured on Ph...
CARBOGEN AMCIS AG Featured on Pharmaceutical Technology Europe

Volume 23, Issue 9, pp. 65-66

14 September 2011

BUBENDORF, Switzerland (September 14, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, was featured on Pharmaceutical Technology Europe (Volume 23, Issue 9, pp. 65-66).


Mark Griffiths, CEO of CARBOGEN AMCIS, was invited to contribute to the section of the magazine covering Highly Potent API Manufacturing. Mr. Griffiths has a broad expertise in High Potency; he managed the design and the construction of the (i) CARBOGEN AMCIS’ High Potency Plant in Bubendorf, Switzerland for the niche supply of Highly Potent APIs (HPAPIs) and (ii) the Dishman Group’s two large-scale manufacturing facilities for commercial supply (up to multi-tonnes scale) of HPAPIs in Shanghai, China and in Ahmedabad, India.


The article is published on Pharmaceutical Technology’s CPhI Preview issue or it can be viewed on line:


If you would like to discuss directly with Mark or one of our representatives how we can assist you with your  HPAPIs requirements, visit us at CPhI Stand 42C04 (Hall 4.1) in Frankfurt from 25-27 October 2011.




CARBOGEN AMCIS AG ( is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd. (, Ahmedabad, India.



Pharmaceutical Technology ( is a monthly magazine published by Advanstar Communications, Inc. with a total qualified circulation of 38,600, according to their website. Pharmaceutical Technology covers process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biotechnology industries.

16 February 2018
CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland

11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

DCAT week

World ADC Berlin